FATE THERAPEUTICS INC (FATE)
FATE THERAPEUTICS INC (FATE)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 39,570 | 46,628 | 40,622 | 41,249 |
| Accounts receivable | 704 | 916 | 682 | 1,395 |
| Short-term investments | 135,252 | 157,029 | 174,801 | 181,581 |
| Prepaid expenses and other current assets | 4,000 | 4,131 | 5,146 | 6,172 |
| Total current assets | 179,526 | 208,704 | 221,251 | 230,397 |
| Long-term investments | 0 | 1,472 | 10,305 | 26,097 |
| Property and equipment, gross | NaN | 93,148 | NaN | NaN |
| Less accumulated depreciation and amortization | NaN | 36,223 | NaN | NaN |
| Property and equipment, net | 54,262 | 56,925 | 59,475 | 61,097 |
| Other assets | NaN | 0 | 0 | 0 |
| Operating lease right-of-use assets | 41,078 | 41,609 | 42,413 | 43,814 |
| Restricted cash | 10,050 | 10,227 | 10,227 | 10,227 |
| Total assets | 284,916 | 318,937 | 343,671 | 371,632 |
| Accounts payable | 3,277 | 2,656 | 3,504 | 4,040 |
| Accrued expenses | 13,642 | 20,024 | 17,571 | 18,182 |
| Cirm award liability, current portion | 8,448 | 8,448 | 2,280 | 795 |
| Deferred revenue | 582 | 381 | 5 | 0 |
| Operating lease liabilities, current portion | 4,740 | 4,562 | 4,751 | 5,656 |
| Total current liabilities | 30,689 | 36,071 | 28,111 | 28,673 |
| Cirm award liability, net of current portion | 2,112 | 2,112 | 6,590 | 5,600 |
| Operating lease liabilities, net of current portion | 72,045 | 73,287 | 74,494 | 75,675 |
| Stock price appreciation milestones | 363 | 283 | 410 | 320 |
| Preferred stock, 0.001 par value authorized shares - 5,000,000 class a convertible preferred shares issued and outstanding - 2,755,086 at march 31, 2026 and december 31, 2025 | 3 | 3 | 3 | 3 |
| Common stock, 0.001 par value authorized shares - 350,000,000 issued and outstanding - 116,272,513 at march 31, 2026 and 115,359,735 at december 31, 2025 | 116 | 115 | 115 | 115 |
| Additional paid-in capital | 1,745,187 | 1,741,259 | 1,735,730 | 1,730,869 |
| Accumulated other comprehensive income (loss) | -77 | 116 | 153 | 62 |
| Accumulated deficit | -1,565,522 | -1,534,309 | -1,501,935 | -1,469,685 |
| Total stockholders equity | 179,707 | 207,184 | 234,066 | 261,364 |
| Total liabilities and stockholders equity | 284,916 | 318,937 | 343,671 | 371,632 |